Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Unchained Labs keeps them coming, acquires rap.ID!

Unchained Labs
Posted on: 27 Mar 18
Unchained Labs keeps them coming, acquires rap.ID!

PR Newswire

PLEASANTON, Calif., March 27, 2018

PLEASANTON, Calif., March 27, 2018 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics researchers the right tool for the job, acquired rap.ID today. Rap.ID is a leading provider of systems used for particle identification in biopharmaceutical development and quality control. The company also provides contract services in these areas.  This is Unchained Labs' 6th acquisition in just over 3 years.

Particles muck up the quality of a drug and can shut down its production. Single Particle Explorer is the only tool out there that identifies particles by their shape and then forensically identifies them by their chemical and elemental fingerprints. In minutes, researchers know the culprit without a doubt, can track it back to the source, and fix their workflow or manufacturing process.

Silicone oil makes it easier to dispense drugs from injectable devices. Layer Explorer lets researchers measure the thickness and consistency of the silicone, so they can fine-tune their processes to use only a thin, uniform layer to minimize the amount that gets into their formulation.

"These products are great additions to our biologics tools arsenal. We can now help our customers identify the source of any particle that shows up in their process," said Tim Harkness, Founder and CEO of Unchained Labs. "This acquisition expands our portfolio firmly downstream into biologic quality control."

"Unchained Labs is an ideal home for our products and employees," said Dr. Oliver Valet, Managing Director of rap.ID. "They have a great platform to help realize the potential for our products."

In just over 3 years, Unchained Labs has grown to over 180 employees, $50M+ in revenue, 9 product lines and has direct distribution around the world. In connection with this transaction, the company raised $17M in a Series D financing. Novo Ventures, Canaan Partners, TPG Biotech and Tri-Valley Ventures all participated in the financing.

About Unchained Labs
Here's the deal. We're all about helping biologics researchers break free from tools that just don't cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That's our mantra, our promise and we own it. We're located in Pleasanton, CA and can be found online at www.unchainedlabs.com.

Contact:
Taegen Clary
VP of Marketing, Unchained Labs
taegen.clary@unchainedlabs.com 
+1 925 587 9806

 

View original content with multimedia:http://www.prnewswire.com/news-releases/unchained-labs-keeps-them-coming-acquires-rapid-300619047.html

SOURCE Unchained Labs

PR Newswire
www.prnewswire.com

Last updated on: 27/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.